RAD51L3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.088100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.781600E-01
Normal-vs-Stage2
5.113700E-02
Normal-vs-Stage3
1.414190E-01
Normal-vs-Stage4
3.110400E-01
Stage1-vs-Stage2
4.807800E-01
Stage1-vs-Stage3
2.867600E-01
Stage1-vs-Stage4
8.818600E-01
Stage2-vs-Stage3
4.621200E-01
Stage2-vs-Stage4
4.688800E-01
Stage3-vs-Stage4
2.059400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.248300E-02
Normal-vs-AfricanAmerican
2.795400E-01
Normal-vs-Asian
8.650200E-02
Caucasian-vs-AfricanAmerican
5.203000E-01
Caucasian-vs-Asian
4.039000E-01
AfricanAmerican-vs-Asian
2.615600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.056000E-02
Normal-vs-Female
1.391810E-01
Male-vs-Female
3.228400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.287400E-01
Normal-vs-Age(41-60Yrs)
2.246200E-01
Normal-vs-Age(61-80Yrs)
6.202300E-02
Normal-vs-Age(81-100Yrs)
5.549900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.565000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.983400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.665800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.527900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.329800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.809600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.251770E-02
Normal-vs-Daily Drinker
3.391700E-02
Normal-vs-Weekly Drinker
1.135780E-01
Normal-vs-Occasional Drinker
1.436580E-01
Normal-vs-Social Drinker
5.358000E-01
Non Drinker-vs-Daily Drinker
6.229200E-01
Non Drinker-vs-Weekly Drinker
5.121600E-02
Non Drinker-vs-Occasional Drinker
2.089400E-01
Non Drinker-vs-Social Drinker
7.809700E-02
Daily Drinker-vs-Weekly Drinker
1.619580E-01
Daily Drinker-vs-Occasional Drinker
4.486800E-01
Daily Drinker-vs-Social Drinker
1.394200E-01
Weekly Drinker-vs-Occasional Drinker
6.207600E-01
Weekly Drinker-vs-Social Drinker
5.460200E-01
Occasional Drinker-vs-Social Drinker
3.428800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.425400E-01
Normal-vs-Grade 2
6.934400E-02
Normal-vs-Grade 3
9.569500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.710200E-01
Grade 1-vs-Grade 3
4.633200E-01
Grade 1-vs-Grade 4
2.425400E-01
Grade 2-vs-Grade 3
8.083000E-01
Grade 2-vs-Grade 4
6.934400E-02
Grade 3-vs-Grade 4
9.569500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.820000E-02
Normal-vs-NonDiabetic
7.126300E-02
Diabetic-vs-NonDiabetic
3.592200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.625000E-01
Normal-vs-NoPancreatitis
8.529700E-02
Pancreatitis-vs-NoPancreatitis
5.838600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.350640E-01
Normal-vs-N1
5.844200E-02
N0-vs-N1
7.763200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.420400E-02
Normal-vs-TP53-NonMutant
1.774240E-01
TP53-Mutant-vs-TP53-NonMutant
1.628990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
